VIP
Also known as Vasoactive Intestinal Peptide
New
Reconstitution & dosing guide
5 mg · 10 mg vial sizes — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only10mg x 10 vials
VIP (VIP10) · Not in current stock
$50 / vial
5mg x 10 vials
VIP (VIP5) · Not in current stock
$35 / vial
Prices per vial · Research use only · Not medical advice.
Neuropeptide with vasodilatory and immunoregulatory roles; appears in mold-illness and pulmonary research discussions.
How to picture it
VIP activates VPAC receptors and raises cAMP, with effects on smooth muscle, secretion, and immune tone — airways, vessels, inflammatory chatter. Picture a multi-organ "relax and regulate" peptide signal. Pulmonary and neuroendocrine research follow it for calm-and-open biology in systems that seize up under inflammation or stress.
Research focus & benefits
- Smooth-muscle and vasodilatory pathway research
- Pulmonary and inflammatory modulation studies
- Neuroendocrine VPAC signaling science
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
Vasoactive intestinal peptide is an endogenous peptide involved in smooth muscle relaxation, secretion, and immune regulation. Some specialty clinics have used VIP nasal sprays in complex chronic-illness protocols (including controversial CIRS/mold frameworks). Evidence quality varies; specialist oversight matters.
Mechanism
VPAC receptor signaling; bronchodilation, anti-inflammatory immune modulation, neurotransmitter roles.
Research uses
- Pulmonary arterial hypertension research
- Neuroimmune modulation
- Cluster headache research (related peptides)
- Specialty chronic inflammatory protocols
Research dosing notes
Specialty clinic protocols only; not self-serve immune therapy.
Half-life / kinetics
Very short
Common research routes
Reported considerations
- Blood pressure changes
- Flushing
- Nasal irritation
- Drug interactions possible
Contraindications / cautions
- Uncontrolled hypotension risk
- Pregnancy
- DIY treatment of serious pulmonary disease
Common research stacks
- Clinic-based multi-modal CIRS protocols (debated evidence)
Legal / access note
Compounded specialty use exists in some clinics; not broadly approved for mold-illness marketing claims.